Form: 3

Initial statement of beneficial ownership of securities

June 4, 2020

FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Sim Brandon
 2. Date of Event Requiring Statement (Month/Day/Year)
05/26/2020		 3. Issuer Name and Ticker or Trading Symbol
Apollo Medical Holdings, Inc. [AMEH]
(Last)
(First)
(Middle)
1668 S. GARFIELD AVENUE, 2ND FLOOR		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Interim Co-COO
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

ALHAMBRA, CA 91801		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 36,663 (1) (2)
D
 
Common Stock 2,000
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Sim Brandon
1668 S. GARFIELD AVENUE
2ND FLOOR
ALHAMBRA, CA 91801		       Interim Co-COO  

Signatures

/s/ Brandon Sim 06/03/2020
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The issuer previously granted 44,589 shares of restricted stock to the reporting person pursuant to the Apollo Medical Holdings, Inc. 2015 Equity Incentive Plan, under which 22,285 shares vested on May 31, 2020 and 22,284 shares shall vest on May 31, 2021, and which grant is accompanied by a tax-offset right entitling the reporting person to receive, upon vesting, a cash payment equal to the tax withholding incurred upon the vesting of shares.
(2) Represents the grant of 44,589 shares of restricted stock, less 7,906 shares surrendered to offset against withholding tax liability incurred in connection with vesting of shares on May 31, 2020.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.